Diagnostics News and Research

RSS

Scientists develop reliable way of detecting prostate and bladder cancers

A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.

From Randox Laboratories Ltd. 6 Mar 2014

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

6 Mar 2014

Researchers find 69% rise in pertussis vaccination rate among new mothers

Changing the hospital orders for women who have just delivered a child led to a 69% increase in the new mothers' pertussis vaccination rate, providing protection for themselves and their newborns against the disease, commonly known as whooping cough, according to a study in the March issue of the American Journal of Obstetrics & Gynecology.

6 Mar 2014

Bruker’s new TopSolids™ software provides accelerated workflow in solid-state NMR for the characterization of protein structures

At Pittcon 2014, Bruker introduced TopSolids™, a new intuitive, workflow-based software package for solid-state NMR in structural biology that provides menu-based, automated setup and acquisition of the most advanced multinuclear multi-dimensional NMR experiments.

5 Mar 2014

Bio-Rad announces release of beta version of the USP Spectral Library

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the release of beta version of USP Spectral Library™ powered by Bio Rad's KnowItAll® software technology platform for spectral analysis, identification, search, data management, and reporting.

From Bio-Rad Laboratories 5 Mar 2014

Metabolon agrees to provide biochemical profiling services to Human Longevity

Metabolon, Inc., the world's leading commercial-stage metabolomics company, announces the signing of an agreement with newly-launched Human Longevity Inc., whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to tackle diseases of aging by building the world's largest and most complete human genotype, microbiome and phenotype database.

5 Mar 2014

GLNT receives allowance of patent for Parkinson's disease monitoring technology

Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.

5 Mar 2014

Small-molecule drug effective in protecting nonhuman primates from lethal Marburg virus

For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.

5 Mar 2014

Removing gut bacteria may play critical role in reducing cancer risk

Bacteria in the gut are essential for the development of intestinal tumors in mice, according to research led by investigators from the Icahn School of Medicine at Mount Sinai. Removing the bacteria may play a critical role in reducing cancer risk, the researchers write, in the March issue of the Journal of Experimental Medicine.

5 Mar 2014

Bruker opens new preclinical imaging center of excellence for the Americas

Bruker (NASDAQ: BRKR) today announced the official opening of a new Preclinical Imaging Center of Excellence for the Americas in Billerica, Massachusetts. The facility offers advanced development, demonstration and support facilities for Bruker’s industry-leading portfolio of preclinical imaging instrumentation and multimodal platforms.

4 Mar 2014

New minispec sample automation system for TD-NMR applications delivers increased productivity and efficiency

At Pittcon 2014 Bruker announced a new sample automation system for the minispec mq and mq-one series, a new easy to use and cost-effective system that brings sample automation to routine Time-Domain (TD)-NMR applications. Its fast sample exchange of 10mm OD sample tubes delivers new levels of maximum throughput and thanks to automated and precise tempering times measurement reliability is improved, significantly boosting productivity of the minispec series.

4 Mar 2014

Bruker announces next generation JuiceScreener™ 3.0

At Pittcon 2014, Bruker today announced the third release of its successful NMR JuiceScreenerTM. The new release comes with significant enhancements that enable the accurate, swift, automated screening of even more fruit juice types from just a single experiment.

4 Mar 2014

Bruker announces successful installation of World’s First compact 900 MHz actively refrigerated magnet for NMR spectroscopy at UCSD

Bruker today announced the successful installation of an Ascend™ Aeon 900 magnet, the world’s first compact, single-story NMR magnet with active refrigeration at the University of California, San Diego (UCSD) in La Jolla, CA.

4 Mar 2014

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM), announced today that they have received orphan drug designation status for their radiopharmaceutical, Gallium-68 DOTATATE.

4 Mar 2014

Advanced Accelerator Applications agrees to acquire 100% shares of Imaging Equipment

Advanced Accelerator Applications, a fast growing international specialist in Molecular Nuclear Medicine (MNM), announced today that it has entered into an agreement to acquire 100% of the shares of Imaging Equipment Ltd, a privately-held UK distributor of nuclear medicine products and technologies, in newly issued AAA shares.

4 Mar 2014

Bruker launches new, improved customer-driven products at Pittcon 2014

At Pittcon 2014, Bruker today announced new product introductions and enhancements for improved performance and customer experience in research, industrial and applied markets.

4 Mar 2014

Nanomedicine – Past, Present and Future

News-Medical speaks to Frank Boehm about the fundamentals of nanomedicine and the nanotechnologies of the future.

4 Mar 2014

Blocking myoferlin gene can reduce breast cancer cell migration

New research suggests that a protein only recently linked to cancer has a significant effect on the risk that breast cancer will spread, and that lowering the protein's level in cell cultures and mice reduces chances for the disease to extend beyond the initial tumor.

4 Mar 2014

Agilent Technologies launhces handheld FTIR spectrometer

Agilent Technologies Inc. today introduced a next-generation mobile spectroscopy product that is ideal for on-site testing in a broad range of applications, including advanced materials, art, historical objects, geology, agriculture, composites, coatings and polymers.

4 Mar 2014

Levels of bisphenol A in men's urine could be marker of prostate cancer

Findings by Cincinnati Cancer Center researchers show that levels of bisphenol A (BPA) in men's urine could be a marker of prostate cancer and that low levels of BPA exposure can cause cellular changes in both non-malignant and malignant prostate cells.

4 Mar 2014